Last reviewed · How we verify
Behcet's disease
Approved treatments
- Imuran · Legacy Pharma
- Abrilada · AbbVie
Adalimumab-afzb binds TNF-alpha and blocks interaction with p55 and p75 cell surface receptors. - Humira · AbbVie
Adalimumab binds TNF-alpha and blocks interaction with p55 and p75 cell surface receptors. - Remicade · Johnson & Johnson
Infliximab binds to TNFα, blocking its interaction with receptors, reducing inflammation and immune responses. - Remicade · Shanghai Biomabs Pharmaceutical Co., Ltd.
- Remicade · Johnson & Johnson
Infliximab-dyyb neutralizes TNFα by binding with high affinity to soluble and transmembrane forms, inhibiting receptor binding. - CYLTEZO · BOEHRINGER INGELHEIM
- IXIFI · PFIZER INC
- Remicade · Johnson & Johnson
Remicade works by binding to and neutralizing tumor necrosis factor, a protein that promotes inflammation and tissue damage. - Humira · Sohag University
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Behcet's disease patent landscape — cliff calendar, originator estates, attackable patents
- Behcet's disease treatment landscape brief
- Behcet's disease treatment updates RSS
Frequently asked questions about Behcet's disease
What drugs treat Behcet's disease?
Tracked treatments include Imuran, Abrilada, Humira, Remicade, CYLTEZO, IXIFI.
What is the treatment for Behcet's disease?
Standard treatment for Behcet's disease includes Imuran, Abrilada, Humira, Remicade, CYLTEZO. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Behcet's disease patent cliff · Behcet's disease CI report
- Treatment: Imuran · Legacy Pharma
- Treatment: Abrilada · AbbVie
- Treatment: Humira · AbbVie
- Treatment: Remicade · Johnson & Johnson
- Treatment: Remicade · Shanghai Biomabs Pharmaceutical Co., Ltd.
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing